Phenobiome

PhenoBiome is a B2B microbiome science company that helps health organizations and innovative consumer brands turn microbial data into actionable products and interventions. Its platform focuses on functional microbiome intelligence rather than species-only analysis, translating sequencing data into insights about what microbial communities are doing and how those functions may affect health. The company positions itself as a partner for organizations working in clinical and commercial settings, including health systems, health plans, functional practitioners, pharmaceuticals, nutraceuticals, medical nutrition, diagnostics, functional foods, functional beverages, and cosmetics. It offers both turnkey clinical solutions and co-development of proprietary formulas, with an emphasis on clinically validated, market-ready outputs. Core Values Scientific rigor : PhenoBiome emphasizes a research foundation built over more than 16 years and rooted in work developed at Sanford Burnham Prebys. Its platform is presented as evidence-based and grounded in deep microbiome science. Actionable innovation : The company focuses on turning complex microbiome data into practical outputs that partners can use to create products, interventions, and claims. The goal is not just analysis, but innovation that can be deployed in market. Clinical validation : PhenoBiome highlights formal validation studies of 60 to 90 days to test formulas and interventions. This reflects a commitment to proving efficacy before commercialization. Precision and personalization : Its approach centers on identifying functional imbalances and tailoring solutions to specific microbiome needs. That precision is intended to improve relevance and effectiveness for end users. Unique Aspects Function-first microbiome platform : Unlike traditional microbiome analysis that identifies only which species are present, PhenoBiome analyzes microbial phenotypes and functions. This gives partners a more actionable view of metabolic activity, nutrient metabolism, vitamin synthesis, and related effects on host health. Broad microbiome coverage : The platform is described as applicable across gut, skin, vaginal, and oral microbiome segments. That breadth gives the company versatility across multiple health and wellness categories. Deep research heritage : PhenoBiome says its core platform was developed over 16+ years of research at Sanford Burnham Prebys Medical Discovery Institute. The scientific team also cites publications in Nature, Science, and the New England Journal of Medicine. Commercially experienced leadership : The team includes founders and executives with prior exits and leadership roles in healthcare, biotech, and digital health. This combines scientific depth with experience bringing products to market.